Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Bellerophon Therapeutics

16/08/2023 17:58

* Bellerophon Therapeutics Inc  BLPH.OQ  reported a
quarterly
adjusted loss of 42 cents​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 42 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Bellerophon Therapeutics Inc's reported EPS for the
quarter was
a loss of 42 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Bellerophon Therapeutics Inc shares had fallen by 42.0%
this
quarter and lost 55.6% so far this year.
    * The company reported a quarterly loss of $5.14 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 16 at 04:58 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.42          -0.42          Met
 Mar. 31 2023      -0.49          0.27           Beat
 Dec. 31 2022      -0.48          -0.53          Missed
 Sep. 30 2022      -0.58          -0.53          Beat